State of New Jersey Common Pension Fund D Boosts Stock Position in Ventas, Inc. $VTR

State of New Jersey Common Pension Fund D increased its stake in shares of Ventas, Inc. (NYSE:VTR) by 2.3% in the fourth quarter, HoldingsChannel reports. The firm owned 395,692 shares of the real estate investment trust’s stock after buying an additional 9,006 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Ventas were worth $30,619,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in VTR. Vanguard Group Inc. increased its position in Ventas by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 75,948,003 shares of the real estate investment trust’s stock worth $5,876,856,000 after purchasing an additional 2,349,176 shares in the last quarter. UBS Group AG boosted its stake in Ventas by 142.4% in the 3rd quarter. UBS Group AG now owns 3,507,841 shares of the real estate investment trust’s stock worth $245,514,000 after buying an additional 2,060,770 shares during the last quarter. Lasalle Investment Management Securities LLC boosted its stake in Ventas by 1,135.1% in the 3rd quarter. Lasalle Investment Management Securities LLC now owns 1,552,880 shares of the real estate investment trust’s stock worth $108,686,000 after buying an additional 1,427,151 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. boosted its stake in Ventas by 74.2% in the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 2,586,405 shares of the real estate investment trust’s stock worth $181,022,000 after buying an additional 1,101,948 shares during the last quarter. Finally, Invesco Ltd. boosted its stake in Ventas by 21.5% in the 3rd quarter. Invesco Ltd. now owns 5,847,604 shares of the real estate investment trust’s stock worth $409,274,000 after buying an additional 1,034,634 shares during the last quarter. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Analysts Set New Price Targets

A number of analysts have issued reports on the company. Cantor Fitzgerald reissued an “overweight” rating and issued a $93.00 price target on shares of Ventas in a research note on Monday, February 9th. Royal Bank Of Canada raised their price target on Ventas from $83.00 to $91.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 10th. UBS Group reissued a “neutral” rating and issued a $85.00 price target on shares of Ventas in a research note on Monday, February 9th. The Goldman Sachs Group reissued a “buy” rating and issued a $100.00 price target on shares of Ventas in a research note on Monday, February 9th. Finally, Mizuho raised their price target on Ventas from $87.00 to $94.00 and gave the stock an “outperform” rating in a research note on Wednesday, March 4th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $91.47.

Insider Activity

In other news, CEO Debra A. Cafaro sold 10,322 shares of Ventas stock in a transaction dated Monday, February 2nd. The stock was sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. The trade was a 0.92% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, EVP Carey S. Roberts sold 35,532 shares of Ventas stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $85.00, for a total value of $3,020,220.00. Following the completion of the transaction, the executive vice president directly owned 72,755 shares in the company, valued at $6,184,175. This represents a 32.81% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.53% of the company’s stock.

Ventas Stock Performance

NYSE VTR opened at $87.99 on Friday. The firm has a market capitalization of $41.84 billion, a P/E ratio of 159.98, a P/E/G ratio of 2.15 and a beta of 0.75. Ventas, Inc. has a 1-year low of $61.76 and a 1-year high of $88.41. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.67. The business’s 50-day simple moving average is $84.79 and its 200-day simple moving average is $80.03.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion during the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The business’s revenue for the quarter was up 22.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.84 earnings per share. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. Equities analysts predict that Ventas, Inc. will post 3.85 EPS for the current year.

Ventas Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st were paid a $0.52 dividend. The ex-dividend date of this dividend was Tuesday, March 31st. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. This is an increase from Ventas’s previous quarterly dividend of $0.48. Ventas’s dividend payout ratio is presently 378.18%.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.